Ventricular Fibrillation
📧 Sign up to get email alerts when something new happens for Ventricular Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Evaluation of SC-V Versus Conventional CPR [Phase 3]
A Phase 3 trial evaluating SC-V versus conventional CPR has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-12Clinical Trial Update: Implantable Cardioverter Defibrillator (ICD) Support Groups and Veterans
Emory University-sponsored ICD study focusing on veteran participants has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.
The OMNI Study, a Medtronic device trial evaluating therapies in pacemakers, defibrillators, and cardiac resynchronization therapy devices, …
-
CLINICAL_TRIALS trial_result · 2013-07-29Clinical Trial Update: Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE) [Phase 3]
Phase 3 CASCADE trial evaluating conventional therapy versus amiodarone for arrhythmias and cardiac arrest has completed.
-
FDA approval · 2013-05-31FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for amiodarone hydrochloride submitted by Chartwell RX, LLC. This marks an approval of a supplement …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-05-21FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Gland Pharma Limited)
The FDA approved a supplemental application for amiodarone hydrochloride from Gland Pharma Limited, enabling its generic use.
-
FDA approval · 2013-04-29FDA Approved: NEXTERONE — Supplemental Application (Baxter Healthcare Company)
FDA approved a supplemental application for NEXTERONE (amiodarone hydrochloride) submitted by Baxter Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: DATAS: The Dual Chamber & Atrial Tachyarrhythmias Adverse Events Study [NA]
This is a completed Medtronic trial (DATAS) evaluating adverse events related to dual-chamber and atrial tachyarrhythmias in patients with i…
-
CLINICAL_TRIALS trial_result · 2012-05-08Clinical Trial Update: Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS [Phase 2]
Phase 2, randomized, double-blind, placebo-controlled, dose-ranging study evaluating SSR149744c at 100 mg or 300 mg for the prevention of ve…
-
FDA approval · 2011-12-12FDA Approved: NEXTERONE — Supplemental Application (Baxter Healthcare Company)
FDA approved a supplemental application for NEXTERONE (amiodarone hydrochloride) from Baxter Healthcare Company.
-
FDA approval · 2011-08-17FDA Approved: BETAPACE — Supplemental Application (Legacy Pharma USA, Inc.)
FDA approved a supplemental application for BETAPACE (sotalol hydrochloride) from Legacy Pharma USA, Inc.
-
CLINICAL_TRIALS trial_result · 2011-05-25Clinical Trial Update: Benefits of Implantable Cardioverter Defibrillator Follow-up Using Remote Monitoring [NA]
A completed clinical trial update evaluating the benefits of remote-monitoring follow-up for patients with implantable cardioverter-defibril…
-
CLINICAL_TRIALS trial_result · 2011-02-16Clinical Trial Update: CONNECT Study - Clinical Evaluation Of Remote NotificatioN to rEduCe Time to Clinical Decision [NA]
The CONNECT study evaluated a remote notification system to reduce time to clinical decision in patients with arrhythmia-related conditions.…
-
CLINICAL_TRIALS trial_result · 2011-01-17Clinical Trial Update: Remote Follow-up of Patients Receiving Implantable Cardioverter Defibrillator for Prophylactic Therapy [Phase 4]
A Phase 4 clinical trial assessing remote follow-up for patients with implantable cardioverter defibrillators for prophylactic therapy has c…
-
FDA approval · 2010-08-31FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for amiodarone hydrochloride from Zydus Lifesciences Limited, authorizing the continued marketing of…
-
FDA approval · 2010-02-04FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, approving the supplemental filing f…
-
FDA approval · 2010-02-04FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2009-12-01FDA Approved: PACERONE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for PACERONE (amiodarone hydrochloride) by Upsher-Smith Laboratories, LLC, indicating a labeling or …
-
FDA approval · 2009-11-20FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Gland Pharma Limited)
FDA approved a supplemental application for amiodarone hydrochloride from Gland Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2009-10-19Clinical Trial Update: SmartCPR Trial: An Analysis of a Waveform-Based Automated External Defibrillation (AED) Algorithm on Survival From Out-of-Hospital Ventricular Fibrillation [NA]
A completed clinical trial evaluating a waveform-based AED algorithm (SmartCPR) for improving survival after out-of-hospital ventricular fib…
-
CLINICAL_TRIALS trial_result · 2009-08-25Clinical Trial Update: Medtronic Genetic Arrhythmia Markers for Early Detection (GAME Study)
Completed Medtronic study evaluating genetic markers for early detection of arrhythmia risk, with implications for detecting susceptibility …
-
FDA approval · 2009-07-10FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for amiodarone hydrochloride by Hikma Pharmaceuticals USA Inc., granting continued/updated approval …
-
CLINICAL_TRIALS research · 2009-07-02Clinical Trial Update: High Low Biphasic Energy Defibrillation (HiLoBED) [Phase 3]
This Phase 3 clinical trial update covers High Low Biphasic Energy Defibrillation (HiLoBED) for ventricular fibrillation; the current status…
-
CLINICAL_TRIALS trial_result · 2009-06-10Clinical Trial Update: ADVANCE CRT - D: Antitachycardia Pacing (ATP) Delivery for Painless Implantable Cardioverter Defibrillator (ICD) Therapy [Phase 4]
Phase 4 clinical trial update on antitachycardia pacing delivered by implantable cardioverter-defibrillators (ADVANCE CRT-D) with results po…
-
FDA approval · 2009-06-02FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, Inc.